ECCMID 2019

The 29th European Congress of Clinical Microbiology & Infectious Diseases

Thank you for joining us at ECCMID 2019, where visitors discovered how our interdisciplinary solutions can help boost accuracy in their clinical laboratories.

Sign up to download scientific posters and view video recordings of our symposium presented at ECCMID.

 Sign up

Sign up to Receive Our Scientific Posters
Presented at ECCMID 2019

Multicenter Studies Published at ECCMID

Multicenter Evaluation: Eravacycline 
MIC Results—EUCAST

View data from a study that demonstrated the accuracy of the eravacycline MIC for E. coli using MicroScan Dried Gram-negative MIC panels.

Multicenter Evaluation: Meropenem/ Vaboractam MIC Results—CLSI

See the correlation of results between the meropenem/vaboractam MIC for Enterobacteriaceae using MicroScan Dried Gram-negative MIC panels.

Multicenter Evaluation: Ceftolozane/ Tazobactam MIC Results—EUCAST

Find out how results correlated between the ceftolozane/tazobactam MIC for Enterobacteriaceae and Pseudomonas using MicroScan Dried Gram-negative MIC panels.

New Challenges in Clinical Microbiology: Faster Diagnosis of Sepsis and Critical Routine Susceptibility Testing

Today's laboratories are facing more challenges than ever. Increasing concern over sepsis accelerates the need for accurate, rapid diagnosis. Coupled with the growing threat of emerging antimicrobial resistance (AMR), routine antibiotic susceptibility testing and minimum inhibitory concentration (MIC) accuracy is needed to not only help detect AMR, but also to meet the clinical needs of all patients.

Watch videos from our panel of experts at ECCMID 2019 to learn how the laboratory can help physicians in light of these and other concerns and discover a new solution in the fight against sepsis—the Early Sepsis Indicator.

Video MIC Surveillance, Resistance Mechanisms and Public Health

Explore how systematic collection, analysis, interpretation and timely dissemination of MIC data impacts the planning, implementation and evaluation of public health practice. Learn about the importance of phenotypic MICs and their relevance even when using molecular methods. Understand what impact high-level or low-level resistance mechanisms have on the interpretation of isolates distribution, which may help clinicians go beyond relying solely upon the interpretive breakpoints available today.

Video Susceptibility Testing of Gram-negative Bacteria from Cystic Fibrosis Patients

Learn about the primary pathogens isolated in cystic fibrosis patients and consider these microorganisms’ relative antimicrobial susceptibility. How should MIC values be interpreted when there are no interpretive breakpoints for some of these non-fermenting Gram-negative bacteria? Watch Dr. Samantha Sottotetti of the Cystic Fibrosis Microbiology Laboratory explain.

Video Using Hematology Assays to Assess Sepsis Risk

Learn what sepsis is, how clinicians identify sepsis, and how and when to diagnose sepsis. Specifically, familiarize yourself with the latest hematologic findings in sepsis and gain insights that could help your institution achieve early sepsis identification for more effective antibiotic administration.

Video Accuracy of MICs

Understand the sources of uncertainty in antimicrobial susceptibility testing—interlaboratory variability, biological differences, incubation temperature fluctuations, time ranges, proximity to interpretive breakpoints and others. Learn about the Area of Technical Uncertainty and other factors in setting EUCAST breakpoints. Discover how correct classification of antibiotic resistance demands a persistent, multifaceted approach to analysis.

Video Panel Discussion

Gain new insights from this interactive panel discussion among industry thought leaders. The answers to a range of questions from the symposium’s cochairs, as well as attendees, shed additional light on the importance of achieving accurate antimicrobial susceptibility testing and early diagnosis of sepsis.

Boost Accuracy in Your Lab

Microbiology

 

Urinalysis

 

Hematology

MALDI Biotyper is the property of Bruker Daltronik GmbH.

SH2000 is a trademark of EOS srl.